Activated AMPK is able to exert anti-cancer cell activity by regulating its targets, including mammalian target of rapamycin (mTOR) complex 1 (mTORC1) inhibition50–52, autophagy induction52–54 and degradation of various oncogenes27,55. This evidence concerns the gene PRKAA1 and cancer.